Skip to main content
Advertisement
Advertisement

TDOC

TDOC logo

Teladoc Health, Inc.

6.58
USD
Sponsored
+0.08
+1.23%
Sep 15, 15:59 UTC -4
Closed
exchange

After-Market

6.59

+0.01
+0.15%

TDOC Earnings Reports

Positive Surprise Ratio

TDOC beat 26 of 43 last estimates.

60%

Next Report

Date of Next Report
Oct 27, 2026
Estimate for Q3 26 (Revenue/ EPS)
$602.13M
/
-$0.21
Implied change from Q2 26 (Revenue/ EPS)
-0.79%
/
--
Implied change from Q3 25 (Revenue/ EPS)
-3.88%
/
-25.00%

Teladoc Health, Inc. earnings per share and revenue

On Jul 29, 2026, TDOC reported earnings of -0.21 USD per share (EPS) for Q2 26, beating the estimate of -0.25 USD, resulting in a 17.61% surprise. Revenue reached 606.93 million, compared to an expected 627.70 million, with a -3.31% difference. The market reacted with a -28.32% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 21 analysts forecast an EPS of -0.21 USD, with revenue projected to reach 602.13 million USD, implying an increase of 0.00% EPS, and decrease of -0.79% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
InnovAge Holding Corp. Common Stock
Report Date
Sep 08, 2026 For Q4 26
Estimate
$0.07
Actual
$0.06
Surprise
-19.79%
logo
MiniMed Group, Inc. Common Stock
Report Date
Sep 01, 2026 For Q1 27
Estimate
$0.09
Actual
$0.00
Surprise
-100.00%
FAQ
For Q2 2026, Teladoc Health, Inc. reported EPS of -$0.21, beating estimates by 17.61%, and revenue of $606.93M, -3.31% below expectations.
The stock price moved down -28.32%, changed from $9.18 before the earnings release to $6.58 the day after.
The next earning report is scheduled for Oct 27, 2026.
Based on 21 analysts, Teladoc Health, Inc. is expected to report EPS of -$0.21 and revenue of $602.13M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement